The drugmaker will provide fill and finish manufacturing capacity, which will take place at its facility in Ridgefield, N.J.
Sanofi has now committed to manufacturing all three COVID-19 vaccines authorized for emergency use in the U.S., as the drugmaker has also signed agreements to produce the vaccines designed by Pfizer and Johnson & Johnson.
More articles on pharmacy:
8 key COVID-19 vaccine administration errors
COVID-19 vaccine surplus rose by 30% in 2 weeks
US resumes use of J&J’s COVID-19 vaccine
